Key facts
- It has raised $2.6M; the latest was Seed Round ($2.1M) in Apr 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Khona Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Khona Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Khona Scientific
Developer of a cannabinoid biosynthesis platform designed for the targeted manufacture of complex organic compounds. The company utilizes a novel biosynthetic production platform for efficient and scalable manufacturing to provide high-quality, regulatory-compliant cannabinoids for consumer applications, enabling consumers to get quality and regulatory-compliant cannabinoids.
- Sector
- Healthcare
- HQ
- Boulder, CO, United States
- Founded
- 2019
- Employees
- 3
- Website
- khonascientific.com/
- Ownership
- Privately Held (backing)
Khona Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Khona Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Khona Scientific in its N-PORT filings yet. We sweep new filings monthly.